¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chain conformation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conformation
    ÀÔüÇüÅÂ
  • closed chain
    ´ÝÈù»ç½½
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • chain
    »ç½½, ¿¬¼â
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ(¼ú)
  • chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • food chain
    ¸ÔÀ̻罽
  • gamma chain disease
    °¨¸¶»ç½½º´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain
    »ç½½
  • light chain
    °¡º­¿î»ç½½, °æ¼â
  • respiratory chain
    È£Èí»ç½½
  • side chain
    °ç»ç½½
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conformation
    ÀÔüÇüÅÂ
  • chain
    »ç½½
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ¼ú
  • chain fiber
    (¢¡nuclear chain fiber) Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • closed chain
    ´ÝÈù»ç½½
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • food chain
    ¸ÔÀ̻罽
  • heavy chain
    ¹«°Å¿î»ç½½, Áß¼â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • H chain
    Áß¼â, Á߻罽, H¼â
  • H chain disease
    H-¼âº´, Á߼⺴.
  • H chain disease
    Á߼⺴
  • J chain
    J¼â, J»ç½½
  • J chain
    J »ç½½
  • L chain
    °æ¼â, °æ»ç½½, L¼â
  • Mu heavy chain disease
    Mu Áß¼âÁúȯ
  • PCR(polymerase chain reaction)
    ÁßÇÕ¿¬¼â¹ÝÀÀ
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • heavy chain
    Áß¼â
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conformation
    ÀÔü ÇüÅÂ.
  • alpha (¥á) chain
    ¾ËÆÄ»ç½½, ¾ËÆÄ¼â
  • alpha (¥á) chain disease
    ¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • atomic chain
    ¿øÀÚ¼â(ê«í­áð).
  • beta (¥â) chain
    º£Å¸»ç½½, º£Å¸¼â
  • branched chain amino acid
    ºÐÁö¼â¾Æ¹Ì³ë»ê
  • chain
    »ç½½, ¼â
  • chain
    ¿¬¼â(ææáð), ¼â(áð), °í¸®, »ç½½.
  • chain combination
    ¿¬¼â°áÇÕ.
  • chain compound
    »ç½½È­ÇÕ¹°.
  • chain cystourethrography
    °í¸® ¹æ±¤¿äµµ Á¶¿µ¼ú
  • chain fiber
    ¿¬¼â¼¶À¯(ææáðàéë«)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ¼â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain conformation
    »ç½½ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • beta conformation
    º£Å¸ ÀÔü ÇüÅÂ(í¡ô÷ û¡÷¾)
  • boat conformation
    º¸¿ìÆ® ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • chair conformation
    ÀÇÀÚÇü ÀÔüÇüÅÂ(ëõí­û¡ Ø¡ô÷û¡÷¾)
  • condensed conformation
    ÃàÇÕ ÀÔüÇüÅÂ(õêùêØ¡ô÷û¡÷¾)
  • conformation
    ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • cross-¥â-conformation
    ±³Â÷-¥â-ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • eclipsed conformation
    °¡¸² ÀÔüÇüÅ (Ø¡ô÷û¡÷¾)
  • endo conformation
    ³»ºÎ ÀÔüÇüÅ (Үݻءô÷û¡÷¾)
  • energized conformation
    Ãæ(õö)¿¡³ÊÁö ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • envelope conformation
    ºÀÅõ ÀÔüÇüÅ (Üæ÷ߨ¡ô÷û¡÷¾)
  • exo conformation
    ¿ÜºÎ ÀÔüÇüÅ (èâݻءô÷û¡÷¾)
  • gauche conformation
    °í¿À½¬ ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
  • native conformation
    ÀÚ¿¬ÀÔüÇüÅÂ(í»æÔØ¡ô÷û¡÷¾)
  • nonenergized conformation
    ¿¡³ÊÁö¹«±Þ ÀÔüÇüÅ×(ÙíÐ娡ô÷û¡÷¾)
  • orthodox conformation
    ¿À¸£Åäµ¶½º ÀÔüÇüÅÂ(Ø¡ô÷û¡÷¾)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
  • chain cystography
    »ç½½¹æ±¤Á¶¿µ¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
kappa a light chain of human immunoglobulins [chain]
LC Laennec cirrhosis; Langerhans cell; late clamped; large chromophobe; lecithin cholesterol acyltransf...
VH variable domain of heavy chain; variable heavy chain
VL variable domain of the light chain; variable light chain
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PCR-SSCP Polymerase Chain Reaction-Single Strand Conformation Polymorphism
PCR-SSCP Polymerase chain reaction and single strand conformation polymorphism
PCR-SSCP polymerase chain reaction single strand conformation polymorphism analysis
CSGE Conformation sensitive gel electrophoresis
PCR-SSCP PCR single-strand conformation polymorphism
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • branched chain
    Ãø¼â
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
    ¼±»óÀ¸·Î ´ç°ú ´çÀÌ °áÇÕµÈ ÁýÇÕ¹°. ¿¹ÄÁ´ë È­ÇÕ¹°¿¡ À־ ¿øÀÚ È¤Àº ±âÀÇ ÁýÇÕ, ¶Ç´Â °³°³ ¼¼±ÕÀÌ ¿°ÁÖ ¸ð¾çÀ¸·Î µÈ ¼¼Æ÷ ¸ðÀÓ.
  • chain compound
    »ç½½ È­ÇÕ¹°
  • chain fiber
    ¿¬¼â ¼¶À¯
  • chain initiation reaction
    ¿¬¼â °³½Ã ¹ÝÀÀ
  • chain reflex
    ¿¬¼â ¹Ý»ç
    ÇϳªÀÇ Àڱؿ¡¼­ ´ÙÀ½ÀÇ ÀÚ±ØÀ¸·Î Â÷·Ê·Î ÀüÇØÁ®¼­ ¿ÏÀüÇÑ È°µ¿À¸·Î ³ªÅ¸³ª´Â ÀÏ·ÃÀÇ ¹Ý»ç.
  • chain structure
    ¿¬¼â ±¸Á¶
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • H chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain
    H »ç½½, H ¼â, Áß¼â
    1. ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ÇÑ ºÎºÐ. 2. ¸é¿ª ±Û·ÎºÒ¸°À» ±¸¼ºÇϰí ÀÖ´Â µÎ °³ÀÇ ºÐÀÚ¼âÀÇ ºÐÀÚ·®ÀÌ Å« Æú¸®ÆéŸÀ̵带 ¸»ÇÑ´Ù.
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • J chain
    J¼â, J »ç½½, ¿¬°á »ç½½
  • joining chain
    ¿¬°á »ç½½, ¿¬°á ¼â
  • L chain
    °æ¼â, °æ»ç½½, L¼â
  • lambda chain
    ¶÷´Ù »ç½½
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
chain, orthodontic chain <dentistry> A stretchable plastic chain used to hold archwires into brackets and to moke teeth.
(08 Jan 1998)
beta conformation A polypeptide chain (often a secondary structure of a protein) arranged as along zig-zag.
(09 Oct 1997)
boat conformation See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
carbohydrate conformation The characteristic 3-dimensional shape of a carbohydrate.
(12 Dec 1998)
molecular conformation The characteristic three-dimensional shape of a molecule.
(12 Dec 1998)
conformation The three-dimensional arrangement of side groups on a molecule which canfreely rotate into different positions without breaking any bonds.
(09 Oct 1997)
protein conformation The characteristic 3-dimensional shape of a protein, imposed upon it by the secondary and tertiary structure of the peptide chain. This stage in the structure of a protein describes the highest level of organization in overall structure assumed by multimeric proteins (aggregates of more than one polypeptide chain). This is the fourth folding level of protein building.
(12 Dec 1998)
native conformation <chemistry> The conformation in which a molecule is biologically active.
(09 Oct 1997)
nucleic acid conformation The characteristic 3-dimensional shape of a nucleic acid or polynucleotide. Its secondary structure is due to the formation of hydrogen bonds between nucleotides, resulting in base pairing and areas with alpha helix structure.
(12 Dec 1998)
envelope conformation See: Haworth conformational formulas of cyclic sugars.
(05 Mar 2000)
A chain A polypeptide component of insulin containing 21 amino acyl residues, beginning with a glycyl residue (NH2-terminus); insulin is formed by the linkage of an A chain to a B chain by two disulfide bonds; the amino-acid composition of the A chain is a function of species.
Synonym: glycyl chain.
In general, one of the polypeptides in a multiprotein complex.
(05 Mar 2000)
alpha chain disease A vague or indefinite term; could be used for alpha-heavy-chain disease (a lymphoplasma cell proliferative disease usually seen in Mediterranean men, characterised by intestinal involvement with steatorrhoea, often progressive with fatal outcome) or a thalassaemia (a genetic abnormality in the alpha globin chain of haemoglobin).
(05 Mar 2000)
amino acids, branched-chain Amino acids which have a branched carbon chain.
(12 Dec 1998)
B chain A polypeptide component of insulin containing 30 amino acyl residues, beginning with a phenylalanyl residue (NH2-terminus); insulin is formed by the linkage of a B chain to an A chain by two disulfide bonds; the amino-acid composition of the B chain is a function of species.
Synonym: phenylalanyl chain.
(05 Mar 2000)
behaviour chain Related behaviours in a series in which each response serves as a stimulus for the next response.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • conformation
    ÀÏÄ¡
  • conformation
    ÇüÅÂ;±¸Á¶;ÀûÇÕ;ÀÏÄ¡;(ºÐÀÚÀÇ)¹èÁÂ;Á¤ÇÕ;~al
  • chain
    »ç½½
  • Gunter's chain
    °ÇÅÍ Ãø·®¿ë »ç½½(±æÀÌ 66ÇÇÆ®)
  • Markov(Markoff) chain
    ¸¶¸£ÄÚÇÁ ¿¬¼â
  • chain
    ¼è»ç½½;ÀÏ·Ã;¿¬¼â;(¹æ¼ÛÀÇ)³×Æ®¿öÅ©;¸ñ°ÉÀÌ;°í¸®ÁÙ(°üÁ÷ÀÇ Ç¥½Ã·Î¼­ ¸ñ¿¡ °Å´Â);(ÀÚÀü°ÅÀÇ)üÀÎ;µµ¾îüÀÎ;(¿¬¼â °æ¿µÀÇ ÀºÇà.±ØÀå.È£ÅÚ µîÀÇ)üÀÎ(Á¡);¿¬¼âÁ¡;(»ç½½ÀÌ ´Þ¸°)Â÷²¿;Á·¼â;±¼·¹;¼Ó¹Ú;±¸±Ý;Ãø¼â;¤²Ã¼ÀÎ;ȸ·Î;¼è»ç½½ÅºÈ¯;¿¬¼â(¿øÀÚÀÇ);´é»ç½½;(µ¿¹° µîÀ»)»ç½½·Î ¸Å
  • chain armor
    CHAIN MAIL
  • chain belt
    (ÀÚÀü°Å µîÀÇ)Åé´Ï¹ÙÄû¿ë üÀÎ
  • chain brake
    üÀκ극ÀÌÅ©
  • chain bridge
    »ç½½ Á¶±³
  • chain cable
    »ç½½ ´éÁÙ
  • chain coupling
    »ç½½ ¿¬°á±â
  • chain drive
    (µ¿·ÂÀÇ)üÀÎ Àüµ¿;üÀÎ Àüµ¿À» ÀÌ¿ëÇÑ ÀåÄ¡
  • chain gang
    ÇÑ »ç½½¿¡¸ÅÀÎ ¿Á¿Ü ³ëµ¿ Á˼öµé
  • chain gear
    üÀÎ Åé´Ï¹ÙÄû !
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á